Find what you need in the Fundación Valle del Lili

Are you looking for a medical service, a specialty, a healthcare professional, or information about appointments and programs?
Use our smart search engine to easily access everything that the Fundación Valle del Lili.

Services for you

A research study to evaluate the effects of a new oral medicine called Cenerimod in adults with systemic lupus erythematosus – 05648500

Study ID: 05648500

A phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety, and tolerability of cenerimod in adult subjects with moderate to severe systemic lupus erythematosus (SLE) in addition to background therapy

About the study:

 

The purpose of this study is to determine the effect of the study drug (cenerimod) on treating and reducing the symptoms of systemic lupus erythematosus (SLE) when given to adult patients with moderate to severe symptoms. The goal is also to determine how safe cenerimod is for adult patients with SLE. Cenerimod is a newer drug that can reduce the number of certain white blood cells involved in lupus. By doing so, it may help reduce inflammation in your body and improve your symptoms. This study is testing one dose of cenerimod against a placebo. It is important to compare cenerimod to a placebo to determine if cenerimod is truly effective. You will receive either cenerimod or the placebo in addition to the medication you are currently taking to treat your lupus.

Total length

Target audiences

Ages: 18 Years - 75 Years
Sex: All

Location

Idorsia Pharmaceuticals Ltd.

Associated diseases

  • lupus
  • Rheumatology

Request an appointment via WhatsApp
Request a call
Medical Directory
Check results
Contact